These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 17697330)

  • 1. Phosphorylation of Ser78 of Hsp27 correlated with HER-2/neu status and lymph node positivity in breast cancer.
    Zhang D; Wong LL; Koay ES
    Mol Cancer; 2007 Aug; 6():52. PubMed ID: 17697330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomics of breast cancer: enhanced expression of cytokeratin19 in human epidermal growth factor receptor type 2 positive breast tumors.
    Zhang DH; Tai LK; Wong LL; Sethi SK; Koay ES
    Proteomics; 2005 May; 5(7):1797-805. PubMed ID: 15825149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine phosphorylation of PP2A is regulated by HER-2 signalling and correlates with breast cancer progression.
    Wong LL; Chang CF; Koay ES; Zhang D
    Int J Oncol; 2009 May; 34(5):1291-301. PubMed ID: 19360341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathologic characteristics predicting HER-2/neu amplification in breast cancer.
    Prati R; Apple SK; He J; Gornbein JA; Chang HR
    Breast J; 2005; 11(6):433-9. PubMed ID: 16297088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NH2-terminally truncated HER-2/neu protein: relationship with shedding of the extracellular domain and with prognostic factors in breast cancer.
    Christianson TA; Doherty JK; Lin YJ; Ramsey EE; Holmes R; Keenan EJ; Clinton GM
    Cancer Res; 1998 Nov; 58(22):5123-9. PubMed ID: 9823322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vincristine regulates the phosphorylation of the antiapoptotic protein HSP27 in breast cancer cells.
    Casado P; Zuazua-Villar P; del Valle E; Martínez-Campa C; Lazo PS; Ramos S
    Cancer Lett; 2007 Mar; 247(2):273-82. PubMed ID: 16843591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GRB-7 facilitates HER-2/Neu-mediated signal transduction and tumor formation.
    Bai T; Luoh SW
    Carcinogenesis; 2008 Mar; 29(3):473-9. PubMed ID: 17916906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of HER-2/neu receptor positivity and its association with other features of breast cancer.
    Naeem M; Nasir A; Aman Z; Ahmad T; Samad A
    J Ayub Med Coll Abbottabad; 2008; 20(3):23-6. PubMed ID: 19610508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HER-2/neu amplification and overexpression in primary human breast cancer is associated with early metastasis.
    Tiwari RK; Borgen PI; Wong GY; Cordon-Cardo C; Osborne MP
    Anticancer Res; 1992; 12(2):419-25. PubMed ID: 1349794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphoproteome study reveals Hsp27 as a novel signaling molecule involved in GDNF-induced neurite outgrowth.
    Hong Z; Zhang QY; Liu J; Wang ZQ; Zhang Y; Xiao Q; Lu J; Zhou HY; Chen SD
    J Proteome Res; 2009 Jun; 8(6):2768-87. PubMed ID: 19290620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HER-2/neu and p53 overexpression as biomarkers of breast carcinoma in women age 30 years and younger.
    Maru D; Middleton LP; Wang S; Valero V; Sahin A
    Cancer; 2005 Mar; 103(5):900-5. PubMed ID: 15643600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR; Abd-Elwahed SR; Abdulwahed AR
    Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic study reveals that proteins involved in metabolic and detoxification pathways are highly expressed in HER-2/neu-positive breast cancer.
    Zhang D; Tai LK; Wong LL; Chiu LL; Sethi SK; Koay ES
    Mol Cell Proteomics; 2005 Nov; 4(11):1686-96. PubMed ID: 16048908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular-cytogenetic analysis of HER-2/neu gene in BRCA1-associated breast cancers.
    Grushko TA; Blackwood MA; Schumm PL; Hagos FG; Adeyanju MO; Feldman MD; Sanders MO; Weber BL; Olopade OI
    Cancer Res; 2002 Mar; 62(5):1481-8. PubMed ID: 11888924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-expression of ErbB-family members in human breast cancer: Her-2/neu is the preferred dimerization candidate in nodal-positive tumors.
    Hudelist G; Singer CF; Manavi M; Pischinger K; Kubista E; Czerwenka K
    Breast Cancer Res Treat; 2003 Aug; 80(3):353-61. PubMed ID: 14503808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Her-2/neu gene overexpression in breast carcinoma and its association with clinicopathological characteristics of the disease.
    Ahmad A; Bano U; Gondal M; Khan A
    J Coll Physicians Surg Pak; 2009 May; 19(5):297-9. PubMed ID: 19409162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic analysis of HER-2/neu gene amplification in paraffin embedded tumour tissue in women with breast cancer.
    Zadrozny M; Smolarz B; Romanowicz-Makowska H; Kozłowska E; Kulig A
    Pol J Pathol; 2002; 53(4):189-93. PubMed ID: 12597335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heregulin-triggered Her-2/neu signaling enhances nuclear accumulation of p21WAF1/CIP1 and protects breast cancer cells from cisplatin-induced genotoxic damage.
    Menendez JA; Mehmi I; Lupu R
    Int J Oncol; 2005 Mar; 26(3):649-59. PubMed ID: 15703820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCR7 and CXCR4 as novel biomarkers predicting axillary lymph node metastasis in T1 breast cancer.
    Cabioglu N; Yazici MS; Arun B; Broglio KR; Hortobagyi GN; Price JE; Sahin A
    Clin Cancer Res; 2005 Aug; 11(16):5686-93. PubMed ID: 16115904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HER-2/neu oncogene expression in advanced breast cancer.
    Krogerus LA; Leivonen M
    Cancer Detect Prev; 2001; 25(1):1-7. PubMed ID: 11270416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.